With increased testing, reduced quarantine and vaccinations on the horizon, and in order to further support a safe return to travel, Reed & Mackay is pleased to announce two new partnerships with leading medical risk companies to enhance the existing R&M Protect and Care Travel Solution.

Reed & Mackay has launched an exclusive partnership with Healix International to deliver a one-of-a-kind layered risk assessment tool that has been designed to enable business travel within a pandemic, providing instant assessments of the medical and logistical risks posed by each and every unique proposed travel itinerary.

Additionally, with access to rapid testing playing a critical role in the return to travel, Reed & Mackay’s partnership with CityDoc, provides reliable, trustworthy Covid-19 tests to individuals and to organisations with results within 72 hours of the test sample reaching the lab.

You can read the full press release here.